Streetbeat News

CBDL

CBD Life Sciences Inc

Industry

Medicinal and Botanical Manufacturing

Open

0.00

Mkt cap

938K

Volume

75M

High

0.00

P/E Ratio

-0.05

52-wk high

0.03

Low

0.00

Div yield

N/A

52-wk low

0.00

CBD Life Sciences Inc. (CBDL) plans to acquire a cannabis growth license in North Las Vegas, valued at $10 million, with projected 2025 gross revenue of $5 million. This positions CBDL for significant growth in Nevada's cannabis market, expected to exceed $1.3 billion by 2025.

Portfolio Pulse from

December 11, 2024 | 1:15 pm

CBD Life Sciences Inc. (CBDL) has signed a Letter of Intent to acquire an interest in a cannabis dispensary in New York, potentially generating $8 million in revenue. This move positions CBDL for significant growth in the expanding New York cannabis market, projected to exceed $5 billion by 2027.

Portfolio Pulse from

November 19, 2024 | 1:15 pm

CBD Life Sciences Inc. (CBDL) is applying for a beer and liquor license to sell its own CBD-infused wine, aiming to capitalize on the projected $2.1 billion U.S. CBD-infused beverage market by 2025. This move positions CBDL as a key player in the growing CBD alcohol sector.

Portfolio Pulse from

November 13, 2024 | 1:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.